-
Mashup Score: 69National Cancer Institute Designates Jefferson’s Sidney Kimmel Cancer Center as a Comprehensive Cancer Center | Jefferson Health - 14 day(s) ago
This recognition places Sidney Kimmel Cancer Center among a group of only 57 cancer centers nationwide, providing exceptional and personalized cancer care.
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6SKCC Researchers Investigate Tumor-Immune Cell Crosstalk in Aggressive Form of Prostate Cancer | Jefferson Health - 3 month(s) ago
Prostate cancer is the second most commonly diagnosed cancer among men worldwide. Researchers at the Sidney Kimmel Cancer Center – Jefferson Health (SKCC) are working to better understand neuroendocrine prostate cancer (NEPC), a particularly aggressive form of the disease that arises after the initial treatment of prostate cancer.
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet-
New research from SKCC member @LLanguino & colleagues shows that extracellular vesicles from #prostatecancer patients promote a pro-tumorigenic microenvironment. The study describes a potential new treatment strategy. Read more: https://t.co/GnLXxVqfAE #JeffersonResearch https://t.co/WzsrreRh2j
-
-
Mashup Score: 4A Study of PARG Inhibitor IDE161 in Participants with Advanced Solid Tumors | Jefferson Health - 5 month(s) ago
Copyright © 2023 Thomas Jefferson University Hospitals. All Rights Reserved. Jefferson holds itself accountable, at every level of the organization, to nurture an environment of inclusion and respect, by valuing the uniqueness of every individual, celebrating and reflecting the rich diversity of its communities, and taking meaningful action to cultivate an environment of fairness, belonging &…
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet-
#TrialTuesday: @KayvanZarrabi is leading a first-in-human trial evaluating the safety, efficacy, & tolerability of the PARG inhibitor IDE161 as a monotherapy in metastatic solid tumors harboring BRCA1/2 mutations or other HR defects now enrolling at SKCC: https://t.co/0RatzX3BpL https://t.co/Eg0fWl27bq
-
-
Mashup Score: 6
S1914, A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC. This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body’s immune…
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet-
#TrialTuesday: Dr. Maria Werner-Wasik is leading a trial studying whether adding the immunotherapy drug atezolizumab to the usual radiation therapy works better in treating patients with early-stage non-small cell lung cancer. https://t.co/QSMiioFylg #LungCancerAwareness #RadOnc https://t.co/qpyxj0pvLl
-
-
Mashup Score: 10Pancreatic Cancer | Jefferson Health - 6 month(s) ago
As part of Sidney Kimmel Cancer Center (SKCC), we provide world renowned pancreatic cancer care, complete with NCI clinical trials and support services.
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today is #WorldPancreaticCancerDay. Today and always, we are here for our patients & their families while we work toward a future with better ways to treat, cure, prevent, & detect #PancreaticCancer. Learn about the risks, treatment options, & more: https://t.co/j0AkCKIsJ6 #WPCD https://t.co/o76qOhTTEb
-
-
Mashup Score: 0Cancer Prevention Screening Day | Jefferson Health - 7 month(s) ago
Join us for on-site screenings, as well as cancer prevention and health & wellness education and tips.
Source: www.jeffersonhealth.orgCategories: General Medicine News, Onc News and JournalsTweet-
Call 267-734-3947 to register for a FREE #CancerScreening this Saturday, Oct. 21, at the Cancer Prevention Screening & Education Day @jeffersonhealthNE! SKCC experts will also be providing info on cancer prevention and health & wellness. https://t.co/9JCliOLuzH https://t.co/q80pC6LTgv
-
-
Mashup Score: 0
African American Families Fighting Parental Cancer TogetherThe purpose of this study is to test the usefulness of a family-based program for African American parents/primary caregivers with newly diagnosed solid tumor cancer and their adolescent children. The program is designed to promote family communication reduce and depressive symptoms for adolescence.Learn MoreProtocol…
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: "African American Families Fighting Cancer Together" provides free online support for parents/caregivers who have been diagnosed with cancer & their children. Eligible families may receive up to $290 for their time & effort: https://t.co/ksTVhY3CXp https://t.co/rK2FG05tAG
-
-
Mashup Score: 0
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)The objective of this study is to demonstrate superiority of capivasertib + docetaxel relative to placebo + docetaxel by assessment of overall survival (OS) in…
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: Dr. Patrick Mille is leading a #ClinicalTrial assessing the combination of capivasertib + docetaxel vs. docetaxel + placebo in patients with metastatic castration-resistant #ProstateCancer: https://t.co/UXDNPcJBfJ #ProstateCancerAwarenessMonth https://t.co/B7CKxrZRRc
-
-
Mashup Score: 1
This immunotherapy developed by a Jefferson neurosurgeon may increase the lifespan of patients with fast-growing and aggressive brain tumor.
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: A phase IIb trial is now enrolling patients with glioblastoma. IGV-001, a novel immunotherapy developed by Jefferson neurosurgeon & SKCC member Dr. David Andrews, may increase the lifespan of patients with this aggressive tumor. https://t.co/lGicw6QqTJ @imvax_inc https://t.co/dxIb0iLgiD
-
-
Mashup Score: 0
At Sidney Kimmel Cancer Center, we don’t just treat your cancer. We treat you as a whole person—not just a patient—and work to help you reclaim your physical, mental, and emotional wellness.
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Cancer affects people emotionally & psychologically, as well as physically. Our Cancer Support & Welcome Center can connect you and your loved ones with support services to help you navigate a cancer diagnosis. #MentalHealthAwarenessMonth. https://t.co/FjjvdPjG1c https://t.co/Q88FxG7bQn
-
Exciting news 🎉 We are thrilled to announce that the Sidney Kimmel Cancer Center has achieved "Comprehensive Cancer Center" designation, the highest recognition awarded by @theNCI! https://t.co/peExb5g7bW